High-grade gliomas (HGG) pose significant challenges in modern tumour therapy due to the distinct biological properties and limitations of the blood-brain barrier. This review discusses recent advancements in HGG treatment, particularly in the context of immunotherapy and cellular therapy. Initially, treatment strategies focus on targeting tumour cells guided by the molecular characteristics of various gliomas, encompassing chemotherapy, radiotherapy and targeted therapy for enhanced precision. Additionally, technological enhancements are augmenting traditional treatment modalities. Furthermore, immunotherapy, emphasising comprehensive tumour management, has gained widespread attention. Immune checkpoint inhibitors, vaccines and CAR-T cells exhibit promising efficacy against recurrent HGG. Moreover, emerging therapies such as tumour treating fields (TTFields) offer additional treatment avenues for patients with HGG. The combination of diverse treatments holds promise for improving the prognosis of HGG, particularly in cases of recurrence.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11039916 | PMC |
| http://dx.doi.org/10.3389/fonc.2024.1287725 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A sample size analysis of a mathematical model of longitudinal tumor volume and progression-free survival for Bayesian individual dynamic predictions in recurrent high-grade glioma.
CPT Pharmacometrics Syst Pharmacol
December 2024
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Patients with recurrent high-grade glioma (rHGG) have a poor prognosis with median progression-free survival (PFS) of <7 months. Responses to treatment are heterogenous, suggesting a clinical need for prognostic models. Bayesian data analysis can exploit individual patient follow-up imaging studies to adaptively predict the risk of progression.
View Article and Find Full Text PDFS100A8 promotes tumor progression by inducing phenotypic polarization of microglia through the TLR4/IL-10 signaling pathway in glioma.
J Natl Cancer Cent
December 2024
Department of Neurosurgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Background: S100A8 is a member of the S100 protein family and plays a pivotal role in regulating inflammation and tumor progression. This study aimed to comprehensively assess the expression patterns and functional roles of S100A8 in glioma progression.
Methods: Glioma tissues were collected from 98 patients who underwent surgical treatment at Fudan University Shanghai Cancer Center.
A topographic approach to the markers of macrophage/ microglia and other cell types in high grade glioma.
Neurochem Int
December 2024
Department of Neurosurgery, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy. Electronic address:
In glioblastoma, glioma-associated microglia/macrophages (GAMs) represent the major population of tumor infiltrating cells, with up to one half of the cells of the tumor mass. Recent studies have shown that microglia are involved in the maintenance of immunological homeostasis and protection against autoimmunity. However, despite the growing body of evidence on the topic, many aspects are yet to be clarified.
View Article and Find Full Text PDFCognitive Control Network and Language Reorganization in Patients with Brain Tumors.
AJNR Am J Neuroradiol
December 2024
From the Department of Radiology, (Luca Pasquini), Yale New Haven Hospital, Yale Medical School, New Haven, CT, USA; Department of Radiology (Luca Pasquini, Mehrnaz Jenabi, Andrei I. Holodny), Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Medical Physics (Antonio Napolitano, Leonardo Spitoni), Bambino Gesù Children's Hospital, Rome, Italy; Department of Engineering (Maurizio Schmid), University Roma Tre, Rome, Italy; Department of Radiology (Francesco Dellepiane) Bambino Gesù Children's Hospital, Rome, Italy; Department of Medical Physics (Kyung K. Peck), Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Radiology (Andrei I. Holodny), Weill Medical College of Cornell University, New York, NY, USA; Department of Neuroscience (Andrei I. Holodny), Weill Cornell Graduate School of the Medical Sciences, New York, NY, USA.
Background And Purpose: The interaction between language and other cognitive networks in patients harboring brain tumors is poorly understood. We studied the modification of the cognitive control network (CCN) induced by brain tumors and its participation in language reorganization. We hypothesized that patients with brain tumors and reorganized language would show modification of the CCN compared to patients who remain left dominant.
View Article and Find Full Text PDFComparative analysis of intraoperative MRI and early postoperative MRI findings in glioma surgery patients.
J Neurosurg
December 2024
1Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama.
Objective: The extent of resection (EOR) is an important prognostic factor for both low- and high-grade gliomas. Intraoperative MRI (iMRI) has been used to increase the EOR in glioma surgery. While a recent study reported differences between iMRI and early postoperative MRI (epMRI), their specific relationship to postoperative clinical symptoms remains unclear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!